Predicting alternans in the V_m-driven model during a progressive decrease of I_Ks conductance. by Mathieu Lemay (330649)

Cytochalasin D decreases pyroptosis in TLR ligand-activated Raw264.7 cells. by Peeraya Ekchariyawat (3911113)

Neither imatinib nor nilotinib induce a decrease of LTC-IC frequency. by Ludovic Belle (293091)

Fig 5 - by Duyan Geng (12072181)

PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

<i>T. cruzi</i> PCM abrogates MAP kinase activation and decreased MAP kinase signaling results in inhibition of ctgf/ccn2 expression. by G. Adam Mott (198973)

PB + PER exposure decreased SYP staining in the hippocampi and cerebral cortices of exposed mice. by Zuchra Zakirova (431614)

AGE-modification of laminin leads to a decrease in Kir4.1 function. by Kayla Thompson (4885036)

Radiation induces an increase in splenic regulatory T cells with a decrease in T cell proliferation. by Yu Zhou (89766)

Decrease of Paneth cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

One-step and multi-step growth curves each mutant and SVA-WT. by Hai-Fan Zhao (15990862)

Decrease of goblet cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

Effects of KSS on SKF-induced decrease in endogenous ALLO content in the frontal cortex. by Qing-Yun Guo (2007082)

A low dose of BTZ decreases proteasome activity with no effect on cell viability. by A. L. Furfaro (2587792)

Mutation of <i>talB</i> in BAI3 results in a decrease of virulence partially complemented by the induction of <i>OsERF#123</i>. by Tuan T. Tran (5335004)

(A) Shape of the osteotomies during the 3-step MIPS drilling procedure. by Marsel Ganeyev (21453399)

Pharmacologic blockade of 5LO decreases Aβ peptides levels and deposition in the 3×Tg mice via the γ-secretase pathway. by Jin Chu (358006)

Nivalenol (NIV) decreases chondrocyte viability in a dose and duration-dependent manner. by Siyuan Li (178640)

CaA decreases the CSCs-like properties of malignant HaCaT cells. by Ye Yang (297214)

Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”